The U.S. Software as a Medical Device (SaMD) Market reached US$205M in 2024 and is expected to reach US$715M by 2033. The market is being shaped by predictive analytics & remote patient monitoring into healthcare workflows.
https://t.co/Unuq5yulsr #NeuraMetrix#digitalbiomarker
The Global Brain Biomarkers Market is set to nearly triple in size over the next seven years, expanding from USD 14.6B in 2026 to USD 43.7B by 2033, at a compound annual growth rate (CAGR) of 16.93% as per Regal Intelligence.
https://t.co/zgVYRIIQdD #NeuraMetrix#brainbiomarkers
The Neurology Diagnostic and Monitoring Devices Market was valued at USD 12.4 Billion in 2025 and is expected to reach USD 24.9 Billion by 2036, growing at a CAGR of 7.2% from 2026 to 2036.
https://t.co/HIPQEKdYPz #NeuraMetrix#neurotech#digitalbiomarker#typingcadence
Brain Monitoring Market is estimated to be valued at USD 4,154.7 Mn in 2025 and is expected to reach USD 6,715.3 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.1% from 2025 to 2032. https://t.co/tv17iklKVC #brainmonitoring#neurametrix#brainhealthbiomarker
.@Allhealthtech highlight the importance of early diagnosis of brain diseases and tech that can facilitate early detection, including @neurametrix, a digital brain biomarker that detects changes in typing patterns indicative of neurological issues https://t.co/Xi4JHSqS13
Key Players in Digital Neuro Biomarkers Market include NeuraMetrix, Inc. typing cadence SaMD. According to a new research report by SNS Insider, the Digital Neuro Biomarkers Market was valued at USD 539M in 2023 + is projected to reach USD 4592M by 2032 https://t.co/x8I38ILKRb
A @NatureMedicine report projects a 42% lifetime risk for dementia in the US by the year 2060, which is approximately twice the current level. Currently, about 500K cases of dementia are diagnosed annually, and by 2060, about 1M cases/yr will be diagnosed https://t.co/oUX0eFvQ7q
Global Digital Biomarkers Market was valued at US$ 2.03 Bn in 2022 and is forecast to reach a value of US$ 22.28 Bn by 2030 at a CAGR of 34.1% between 2023 and 2030. By @WhaTechAU https://t.co/FUF4MbTs04 #NeuraMetrix#digitalbiomarkers
The @US_FDA supports continued research to understand the role of biomarkers in #Alzheimers + stresses their importance in the successful development of effective treatments for the earliest stages of #AD.
#NeuraMetrix#digitalbiomarker#earlydetection
https://t.co/8X36bd8KLb
The #neurodiagnostics market is estimated to be valued at USD 8.66 Bn in 2024 and is expected to reach USD 14.91 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.1% from 2024 to 2031. By @WhaTechAU https://t.co/Xwda0cJQpH #NeuraMetrix
Happy to announce that our CEO, Jan Samzelius, will be speaking at @HITLABnyc's virtual March Symposium: Nourishing Hearts and Minds & the Unveiling of HIMSS & ViVe! It is free to attend! Please use the link below to register: https://t.co/HjNPrIXw4s
#Digital#Brain#Health market was valued at US $198.1 Bn in 2022 and is expected to reach US $400 Bn by 2032, growing at a CAGR of 7.2% from 2023 to 2032.
Download Full Research Study in Pdf Sample@ https://t.co/iDN4EMUkXh
#DigitalWellbeing#NeuroTechInnovation
The brain monitoring market size is poised to cross US$ 6.7 billion in 2024 and is likely to attain a valuation of US$ 12.5 billion by 2034. By @FMI_Research https://t.co/PzgJzL2Wsm #brainmonitoring#neurametrix
The global neurological biomarkers market is expected to reach US$ 14.4B by 2027 from US$ 5.5B in 2019; it is estimated to grow at a CAGR of 13.0% during 2020-2027. By The Insight Partners (@TIPMarketTrends) https://t.co/Ofy8gjX5KU #digitalbiomarkers#brainhealth#neurology